McGill alumnus tagged to boost capacity and discovery in growing field
Dr. Robert Platt, Professor in the departments of Pediatrics and Epidemiology, Biostatistics and Occupational Health at McGill University’s Faculty of Medicine was officially announced as the inaugural Albert Boehringer (1st) Chair in Pharmacoepidemiology during an event held May 26 at McGill.
By Chris Chipello, McGill Newsroom
Surprisingly complex interactions between neurotransmitter receptors and other key proteins help explain the brain’s ability to process information with lightning speed, according to a new study.
Secondary Contact Information
The discovery that tavilermide induces the production of mucin, a crucial lubricant in tears, offers hope of relief to people who suffer from chronic dry eye disease. The invention and the development of a drug based on this small molecule was made by the team of Dr. H. Uri Saragovi, Senior Investigator at the Lady Davis Institute (LDI) at the Jewish General Hospital and Professor of Pharmacology at McGill University.
Researchers at McGill University have found that sodium – the main chemical component in table salt – is a unique “on/off” switch for a major neurotransmitter receptor in the brain. This receptor, known as the kainate receptor, is fundamental for normal brain function and is implicated in numerous diseases, such as epilepsy and neuropathic pain.
Pharmacology conference: The Medical Profession and the Pharmaceutical Industry--Ethical, Clinical, Scientific and Financial Issues at the Interface
Sponsors: Department of Psychiatry and Department of Family Medicine, Jewish General Hospital; Department of Psychiatry, McGill University; l’Association des médecins psychiatres du Québec.
Organizer: Daniel Frank, MD, Department of Psychiatry, Jewish General Hospital
Presenters: Dr. Carl Salzman, Harvard University; Dr. Denis deBlois, Université de Montréal; Dr. Alan Schatzberg, Stanford University; Dr. Ashley Wazana, McGill University; and Dr. Roger McIntyre, University of Toronto.